Search research articles
Contact Us
Filters
Showing results (321-330 of 344) with videos related to
Page
of 35
Sort By:
Gastroenterologia Y Hepatologia
|
December 3, 2014
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial
C Rodríguez de Miguel, A Serradesanferm, M López-Cerón, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2016
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
Ricard Mesía, Jose A Garcia-Saenz, Alicia Lozano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Leukemia
|
June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?
J Schanz, H Tüchler, F Solé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
European Journal of Neurology
|
February 23, 2021
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020
Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, et al.
Neuro-Oncology
|
January 2, 2024
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group
Philipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology
|
August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
Philipp Karschnia, Jacob S Young, Antonio Dono, et al.
Current Genomics
|
April 4, 2017
Genetic Imbalance in Patients with Cervical Artery Dissection
Caspar Grond-Ginsbach, Bowang Chen, Michael Krawczak, et al.
Neuro-Oncology Advances
|
November 3, 2022
<i>TERT</i> promotor status does not add prognostic information in <i>IDH</i>-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO <i>resect</i> group
Philipp Karschnia, Jacob S Young, Antonio Dono, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 344) with videos related to
Sort By:
Page
of 35
Gastroenterologia Y Hepatologia
|
December 3, 2014
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial
C Rodríguez de Miguel, A Serradesanferm, M López-Cerón, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2016
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
Ricard Mesía, Jose A Garcia-Saenz, Alicia Lozano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Leukemia
|
June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?
J Schanz, H Tüchler, F Solé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
European Journal of Neurology
|
February 23, 2021
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020
Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, et al.
Neuro-Oncology
|
January 2, 2024
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group
Philipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology
|
August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
Philipp Karschnia, Jacob S Young, Antonio Dono, et al.
Current Genomics
|
April 4, 2017
Genetic Imbalance in Patients with Cervical Artery Dissection
Caspar Grond-Ginsbach, Bowang Chen, Michael Krawczak, et al.
Neuro-Oncology Advances
|
November 3, 2022
<i>TERT</i> promotor status does not add prognostic information in <i>IDH</i>-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO <i>resect</i> group
Philipp Karschnia, Jacob S Young, Antonio Dono, et al.
Page
of 35